亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

美羅培南

 
 
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
過期 長期有效
更新 2011-04-16 11:44
 

武漢遠城科技發展有限公司銷售八部

企業會員第16年
資料未認證
保證金未繳納
詳細說明
美羅培南 
英文名稱:Meropenem 
CAS 編號:119478-56-7 
包裝規格:1kg
規格型號:99%  
產品說明: 美羅培南
化學名: (4R,5S,6S)-3-[[(3S,5S)-5-(二甲基氨甲酰基)-3-吡咯烷]
硫]-6-[(1R)-1-羥乙基 ]-4-甲基-7-氧-1-氧雙環[3,2,0]-庚-2-烯-2-羧酸三水合物
CAS: 119478-56-7
分子式與分子量: C17H25N3O5S M383.46
質量標準: USP28
用途:青霉烯類抗生素原料藥.
Meropenem 
CAS No. :119478 -56-7 
Packing: 1kg 
Specification: 99% 
Product Description: meropenem 
Chemical name: (4R, 5S, 6S) -3 - [[(3S, 5S) -5 - (dimethyl carbamyl) 
-3-- pyrrolidine] thio] -6-- [(1R) -1 - hydroxyethyl] -4-- methyl 
-7-- oxygen -1-- oxygen bicyclo [3,2,0] - G -2-- ene -2-- carboxylic acid trihydrate 
CAS: 119478-56-7 
Molecular formula and weight: C17H25N3O5S M383.46 
Quality Standard: USP28 
Uses: carbopenems antibiotic API. 









舉報收藏 0評論 0
更多>本企業其它產品
氯唑沙宗 羅非昔布 美洛昔康 美索巴莫 尼美舒利 帕馬溴 潑尼松龍
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |